Olin Corporation

Olin did not provide consolidated revenue or EPS figures in the prepared remarks; management instead discussed segment and EBITDA drivers. The Freeport, Texas DCM outage reduced second-quarter adjusted EBITDA by $40 million and is expected to reduce third-quarter adjusted EBITDA by about $20 million. Epoxy had its best results in more than 3 years, and Winchester improved year over year in adjusted EBITDA. For Q3, Olin expects Chemicals adjusted EBITDA to be relatively flat, Winchester to improve modestly, and overall adjusted EBITDA to be in the range of $100 million to $200 million. The company ended Q2 with $1.2 billion of available liquidity, expects 2026 capital spending of approximately $200 million, and still expects 2026 to be a cash free tax year plus or minus approximately $20 million. Management expects working capital to be essentially flat for full-year 2026 excluding about $195 million of litigation-related cash payments, and year-end leverage to be approximately 4.5 times.

Kenneth Todd Lane framed the quarter as one shaped by volatile geopolitics, supply disruptions, and Olin’s self-help actions. He emphasized that the Huntsman merger creates a vertically integrated North American chemicals leader with more than $12 billion of sales, and said shareholder feedback has been very supportive. He also highlighted that Olin is focused on value-first commercial execution, Beyond250 cost reductions, and operational discipline across chemicals and Winchester.

Todd A. Slater focused on liquidity, cash flow, and balance-sheet discipline. He said Olin ended the quarter with $1.2 billion of available liquidity, has no bond maturities before 2029, and expects roughly $195 million of legacy litigation cash payments in 2026, including $93 million already paid and $100 million still to come in the second half. He reiterated 2026 capital spending of about $200 million, expected working capital to be essentially flat for the full year excluding those payments, and cash-free tax status for 2026 plus or minus about $20 million. He also said Beyond250 should deliver more than $100 million of incremental structural cost savings in 2026 and that the company is increasingly confident it will exceed its $250 million target by 2028.

Analysts pressed management on how long Frank-related disruption could support pricing, and management said Q2 was the big benefit period while Q3 should normalize at a higher cost level and Q4 could tighten as outages and higher costs filter through. Questions on chlor-alkali and chlorovinyls focused on Middle East capacity, Europe, and restocking; management said China and North American outages matter more, Europe remains weak, and destocking could reverse if customers need to restock. On leverage, management confirmed year-end net debt should rise because of the litigation payments, but argued Olin still generates cash even at relatively low EBITDA levels. Analysts also asked about epoxy FIFO and Winchester cost-outs; management said epoxy should stay positive in Q3 despite a lower FIFO benefit, and Winchester is making strong progress on the $30 million cost-out plan and may exceed it.